A citation-based method for searching scientific literature

Mckenna Longacre, Nicole A Snyder, Genevieve Housman, Meghan Leary, Karolina Lapinska, Sarah Heerboth, Amber Willbanks, Sibaji Sarkar. Int J Mol Sci 2016
Times Cited: 30







List of co-cited articles
84 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


Drug resistance in cancer: an overview.
Genevieve Housman, Shannon Byler, Sarah Heerboth, Karolina Lapinska, Mckenna Longacre, Nicole Snyder, Sibaji Sarkar. Cancers (Basel) 2014
997
20

Hallmarks of cancer: the next generation.
Douglas Hanahan, Robert A Weinberg. Cell 2011
16

Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012.
Jacques Ferlay, Isabelle Soerjomataram, Rajesh Dikshit, Sultan Eser, Colin Mathers, Marise Rebelo, Donald Maxwell Parkin, David Forman, Freddie Bray. Int J Cancer 2015
16

Genetic and epigenetic aspects of breast cancer progression and therapy.
Shannon Byler, Sarah Goldgar, Sarah Heerboth, Meghan Leary, Genevieve Housman, Kimberly Moulton, Sibaji Sarkar. Anticancer Res 2014
121
13

Inhibition of HDAC1 and DNMT1 modulate RGS10 expression and decrease ovarian cancer chemoresistance.
Ercan Cacan, Mourad W Ali, Nathaniel H Boyd, Shelley B Hooks, Susanna F Greer. PLoS One 2014
53
13

EMT and tumor metastasis.
Sarah Heerboth, Genevieve Housman, Meghan Leary, Mckenna Longacre, Shannon Byler, Karolina Lapinska, Amber Willbanks, Sibaji Sarkar. Clin Transl Med 2015
440
10

Cancer development, progression, and therapy: an epigenetic overview.
Sibaji Sarkar, Garrick Horn, Kimberly Moulton, Anuja Oza, Shannon Byler, Shannon Kokolus, McKenna Longacre. Int J Mol Sci 2013
124
10

Demethylation and re-expression of epigenetically silenced tumor suppressor genes: sensitization of cancer cells by combination therapy.
Sibaji Sarkar, Sarah Goldgar, Shannon Byler, Shoshana Rosenthal, Sarah Heerboth. Epigenomics 2013
45
10


Use of epigenetic drugs in disease: an overview.
Sarah Heerboth, Karolina Lapinska, Nicole Snyder, Meghan Leary, Sarah Rollinson, Sibaji Sarkar. Genet Epigenet 2014
146
10

Combination therapy of established cancer using a histone deacetylase inhibitor and a TRAIL receptor agonist.
Ailsa J Frew, Ralph K Lindemann, Ben P Martin, Christopher J P Clarke, Janelle Sharkey, Desiree A Anthony, Kellie-Marie Banks, Nicole M Haynes, Pradnya Gangatirkar, Kym Stanley,[...]. Proc Natl Acad Sci U S A 2008
108
10

Cancer statistics, 2016.
Rebecca L Siegel, Kimberly D Miller, Ahmedin Jemal. CA Cancer J Clin 2016
10


The Effects of Histone Deacetylase Inhibitor and Calpain Inhibitor Combination Therapies on Ovarian Cancer Cells.
Karolina Lapinska, Genevieve Housman, Shannon Byler, Sarah Heerboth, Amber Willbanks, Anuja Oza, Sibaji Sarkar. Anticancer Res 2016
15
20

Targeting genetic and epigenetic alterations in the treatment of serous ovarian cancer.
Johanne I Weberpals, Madhuri Koti, Jeremy A Squire. Cancer Genet 2011
40
6

DNA methylation of tumor suppressor genes in clinical remission predicts the relapse risk in acute myeloid leukemia.
Shuchi Agrawal, Matthias Unterberg, Steffen Koschmieder, Udo zur Stadt, Uta Brunnberg, Walter Verbeek, Thomas Büchner, Wolfgang E Berdel, Hubert Serve, Carsten Müller-Tidow. Cancer Res 2007
74
6

Chromosomal Loop Domains Direct the Recombination of Antigen Receptor Genes.
Jiazhi Hu, Yu Zhang, Lijuan Zhao, Richard L Frock, Zhou Du, Robin M Meyers, Fei-long Meng, David G Schatz, Frederick W Alt. Cell 2015
101
6

Lnc RNA HOTAIR functions as a competing endogenous RNA to regulate HER2 expression by sponging miR-331-3p in gastric cancer.
Xiang-Hua Liu, Ming Sun, Feng-Qi Nie, Ying-Bin Ge, Er-Bao Zhang, Dan-Dan Yin, Rong Kong, Rui Xia, Kai-Hua Lu, Jin-Hai Li,[...]. Mol Cancer 2014
697
6

Comprehensive analysis of lncRNA expression profiles reveals a novel lncRNA signature to discriminate nonequivalent outcomes in patients with ovarian cancer.
Meng Zhou, Yanying Sun, Yifan Sun, Wanying Xu, Zhaoyue Zhang, Hengqiang Zhao, Zhaohua Zhong, Jie Sun. Oncotarget 2016
103
6


Downregulation of LncRNA GAS5 causes trastuzumab resistance in breast cancer.
Wentong Li, Limin Zhai, Hui Wang, Chuanliang Liu, Jinbao Zhang, Weijuan Chen, Qun Wei. Oncotarget 2016
140
6

Molecular mechanisms of drug resistance.
D B Longley, P G Johnston. J Pathol 2005
936
6

UCA1 functions as a competing endogenous RNA to suppress epithelial ovarian cancer metastasis.
Yijun Yang, Yi Jiang, Yicong Wan, Lin Zhang, Jiangnan Qiu, Shulin Zhou, Wenjun Cheng. Tumour Biol 2016
71
6

LncRNA-UCA1 enhances cell proliferation and 5-fluorouracil resistance in colorectal cancer by inhibiting miR-204-5p.
Zehua Bian, Liugen Jin, Jiwei Zhang, Yuan Yin, Chao Quan, Yaling Hu, Yuyang Feng, Heyong Liu, Bojian Fei, Yong Mao,[...]. Sci Rep 2016
260
6

Rapid activation of MDR1 gene expression in human metastatic sarcoma after in vivo exposure to doxorubicin.
A Abolhoda, A E Wilson, H Ross, P V Danenberg, M Burt, K W Scotto. Clin Cancer Res 1999
178
6

The long noncoding RNA HOTAIR contributes to cisplatin resistance of human lung adenocarcinoma cells via downregualtion of p21(WAF1/CIP1) expression.
Zhili Liu, Ming Sun, Kaihua Lu, Jing Liu, Meiling Zhang, Weiqin Wu, Wei De, Zhaoxia Wang, Rui Wang. PLoS One 2013
226
6

NF-κB-HOTAIR axis links DNA damage response, chemoresistance and cellular senescence in ovarian cancer.
A R Özeş, D F Miller, O N Özeş, F Fang, Y Liu, D Matei, T Huang, K P Nephew. Oncogene 2016
163
6


The Evolution of Epigenetics: From Prokaryotes to Humans and Its Biological Consequences.
Amber Willbanks, Meghan Leary, Molly Greenshields, Camila Tyminski, Sarah Heerboth, Karolina Lapinska, Kathryn Haskins, Sibaji Sarkar. Genet Epigenet 2016
26
7

T-oligos inhibit growth and induce apoptosis in human ovarian cancer cells.
Sibaji Sarkar, Douglas V Faller. Oligonucleotides 2011
32
6

Anti-breast cancer effects of histone deacetylase inhibitors and calpain inhibitor.
Megan A Mataga, Shoshana Rosenthal, Sarah Heerboth, Amrita Devalapalli, Shannon Kokolus, Leah R Evans, McKenna Longacre, Genevieve Housman, Sibaji Sarkar. Anticancer Res 2012
26
7

Histone deacetylase inhibitors reverse CpG methylation by regulating DNMT1 through ERK signaling.
Sibaji Sarkar, Ana L Abujamra, Jenny E Loew, Lora W Forman, Susan P Perrine, Douglas V Faller. Anticancer Res 2011
95
6

Circulating biomarkers for detection of ovarian cancer and predicting cancer outcomes.
I Shapira, M Oswald, J Lovecchio, H Khalili, A Menzin, J Whyte, L Dos Santos, S Liang, T Bhuiya, M Keogh,[...]. Br J Cancer 2014
114
6

Ovarian cancer screening and mortality in the UK Collaborative Trial of Ovarian Cancer Screening (UKCTOCS): a randomised controlled trial.
Ian J Jacobs, Usha Menon, Andy Ryan, Aleksandra Gentry-Maharaj, Matthew Burnell, Jatinderpal K Kalsi, Nazar N Amso, Sophia Apostolidou, Elizabeth Benjamin, Derek Cruickshank,[...]. Lancet 2016
517
6


Rare non-epithelial ovarian neoplasms: Pathology, genetics and treatment.
William D Foulkes, Martin Gore, W Glenn McCluggage. Gynecol Oncol 2016
18
11

The miR-200 family controls beta-tubulin III expression and is associated with paclitaxel-based treatment response and progression-free survival in ovarian cancer patients.
Susanna Leskelä, Luis J Leandro-García, Marta Mendiola, Jorge Barriuso, Lucía Inglada-Pérez, Iván Muñoz, Beatriz Martínez-Delgado, Andrés Redondo, Javier de Santiago, Mercedes Robledo,[...]. Endocr Relat Cancer 2010
166
6

Ovarian cancer development and metastasis.
Ernst Lengyel. Am J Pathol 2010
915
6

Detection of microRNA as novel biomarkers of epithelial ovarian cancer from the serum of ovarian cancer patients.
Ye-Won Chung, Hyo-Sook Bae, Jae-Yun Song, Jae Kwan Lee, Nak Woo Lee, Tak Kim, Kyu-wan Lee. Int J Gynecol Cancer 2013
107
6

Urinary microRNA-30a-5p is a potential biomarker for ovarian serous adenocarcinoma.
Jun Zhou, Guanghui Gong, Hong Tan, Furong Dai, Xin Zhu, Yile Chen, Junpu Wang, Ying Liu, Puxiang Chen, Xiaoying Wu,[...]. Oncol Rep 2015
99
6

SiRNA and epigenetic aberrations in ovarian cancer.
Hamed Mirzaei, Foad Yazdi, Rasoul Salehi, Hamid Reza Mirzaei. J Cancer Res Ther 2016
80
6

Cancer epigenetics: tumor heterogeneity, plasticity of stem-like states, and drug resistance.
Hariharan Easwaran, Hsing-Chen Tsai, Stephen B Baylin. Mol Cell 2014
516
6

Histones and their modifications in ovarian cancer - drivers of disease and therapeutic targets.
Deborah J Marsh, Jaynish S Shah, Alexander J Cole. Front Oncol 2014
35
6

Transgenerational epigenetic inheritance: myths and mechanisms.
Edith Heard, Robert A Martienssen. Cell 2014
769
6

A Prospective Evaluation of Early Detection Biomarkers for Ovarian Cancer in the European EPIC Cohort.
Kathryn L Terry, Helena Schock, Renée T Fortner, Anika Hüsing, Raina N Fichorova, Hidemi S Yamamoto, Allison F Vitonis, Theron Johnson, Kim Overvad, Anne Tjønneland,[...]. Clin Cancer Res 2016
50
6

Liquid biopsies: genotyping circulating tumor DNA.
Luis A Diaz, Alberto Bardelli. J Clin Oncol 2014
6

The epigenetics of epithelial-mesenchymal plasticity in cancer.
Wai Leong Tam, Robert A Weinberg. Nat Med 2013
790
6

Effect of screening on ovarian cancer mortality: the Prostate, Lung, Colorectal and Ovarian (PLCO) Cancer Screening Randomized Controlled Trial.
Saundra S Buys, Edward Partridge, Amanda Black, Christine C Johnson, Lois Lamerato, Claudine Isaacs, Douglas J Reding, Robert T Greenlee, Lance A Yokochi, Bruce Kessel,[...]. JAMA 2011
750
6

miR-125b confers resistance of ovarian cancer cells to cisplatin by targeting pro-apoptotic Bcl-2 antagonist killer 1.
Fanfei Kong, Chaoyang Sun, Zhongxian Wang, Lingfei Han, Danhui Weng, Yunping Lu, Gang Chen. J Huazhong Univ Sci Technolog Med Sci 2011
63
6

Signatures of mutational processes in human cancer.
Ludmil B Alexandrov, Serena Nik-Zainal, David C Wedge, Samuel A J R Aparicio, Sam Behjati, Andrew V Biankin, Graham R Bignell, Niccolò Bolli, Ake Borg, Anne-Lise Børresen-Dale,[...]. Nature 2013
6


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.